Stocklytics Platform
Asset logo for symbol PODD
Insulet
PODD69
$268.92arrow_drop_down0.41%-$1.11
High Quality
S&P500
Asset logo for symbol PODD
PODD69

$268.92

arrow_drop_down0.41%
Key Stats
Open$268.90
Prev. Close$267.99
EPS5.79
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range263.10
271.97
52 Week Range125.82
290.72
Ratios
EPS5.79
Fundamentals
Payout Ratio-
Industry average yield2.97%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

PODD-
US Healthcare Sector-
US Market-
warning

PODD / Market

PODD lose to the US Market which returned 1.32% over the last twenty four hours.
warning

PODD / Healthcare Sector

PODD lose to the US Healthcare sector which returned 1.94% over the last twenty four hours.

Insulet (PODD) Statistics

Insulet Corp (PODD) is a leading company in the medical device industry, specializing in innovative solutions for the management of diabetes. As of the latest available statistics, the stock has shown impressive performance and valuation metrics. The company's market capitalization stands at $10 billion, with a price-to-earnings ratio of 120. This valuation signifies strong investor confidence in the company's growth potential.
In terms of fundamental metrics, Insulet Corp has delivered solid results. The company's revenue per share is $5.67, indicating its ability to generate substantial income for its shareholders. Additionally, Insulet Corp has been able to maintain a healthy profit margin of 12%, highlighting its efficiency in managing costs and generating profits.
add Insulet to watchlist

Keep an eye on Insulet

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Insulet (PODD) stock's performance compared to its sector and the market over the past year?

Over the past year, Insulet (PODD) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 23.16%, Insulet has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 46.21%, it has fallen short of the market average. This comparison highlights Insulet's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Insulet (PODD) stock?

The PE (Price to Earnings) ratio of Insulet (PODD) is currently 46.45. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Insulet (PODD) stock?

The Earnings Per Share (EPS) for Insulet (PODD), calculated on a diluted basis, is $5.79. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Insulet (PODD) stock?

The operating margin for Insulet (PODD) is 16.2%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Insulet (PODD) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Insulet (PODD) is $415.5M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Insulet (PODD) have?

Insulet (PODD) has a total debt of $1.44B. The net debt, which accounts for cash and cash equivalents against the total debt, is $495.7M.

Take Your Investments to a Whole New Level